Table 4

Survival outcomes with RIC conditioning

ReferenceNo. of patientsGraftOSDFSTRM
MMURD      
 50 59 PB 29% at 2 y 28% at 2 y 36% at 1 y 
 51 45 PB 64% at 2 y 51% at 2 y 11% at 2 y 
Haploidentical      
 53 61 PB 28% at 2 y 25% at 2 y 42% at 2 y 
 35 49 PB 31% at 1 y 43% at 1 y 10.2% at 100 d 
 38 68 BM 36% at 2 y 26% at 2 y 15% at 1 y 
 78 28 BM 58% at 2 y 51% at 2 y 8% at 2 y 
 87 16 PB 60% at 2 y 60% at 2 y 18% at 2 y 
 40 50 BM 62% at 1 y 48% at 1 y 7% at 1 y 
 56 53 60% BM 64% at 2 y 60% at 2 y 7% at 2 y 
UCB      
 83 30 Single 33% at 1 y 22% at 1 y 27% at 100 d 
 41 43 Double 34% at 3 y 34% at 3 y 28% at 6 mo 
 39 110 Double 45% at 3 y 38% at 3 y 26% at 3 y 
 22 64 Double 46% at 3 y 30% at 3 y 27% at 3 y 
 57 104 75% Single 48% at 1 y 40% at 1 y 28% at 1 y 
 19 32 Double 53% at 2 y 31.2% at 2 y 34% at 2 y 
 40 50 Double 54% at 1 y 46% at 1 y 24% at 1 y 
 91 65 Double 55% at 3 y 34% at 3 y 15% at 3 y 
 21 21 Double 71% at 2 y 55% at 2 y 19% at 6 mo 
ReferenceNo. of patientsGraftOSDFSTRM
MMURD      
 50 59 PB 29% at 2 y 28% at 2 y 36% at 1 y 
 51 45 PB 64% at 2 y 51% at 2 y 11% at 2 y 
Haploidentical      
 53 61 PB 28% at 2 y 25% at 2 y 42% at 2 y 
 35 49 PB 31% at 1 y 43% at 1 y 10.2% at 100 d 
 38 68 BM 36% at 2 y 26% at 2 y 15% at 1 y 
 78 28 BM 58% at 2 y 51% at 2 y 8% at 2 y 
 87 16 PB 60% at 2 y 60% at 2 y 18% at 2 y 
 40 50 BM 62% at 1 y 48% at 1 y 7% at 1 y 
 56 53 60% BM 64% at 2 y 60% at 2 y 7% at 2 y 
UCB      
 83 30 Single 33% at 1 y 22% at 1 y 27% at 100 d 
 41 43 Double 34% at 3 y 34% at 3 y 28% at 6 mo 
 39 110 Double 45% at 3 y 38% at 3 y 26% at 3 y 
 22 64 Double 46% at 3 y 30% at 3 y 27% at 3 y 
 57 104 75% Single 48% at 1 y 40% at 1 y 28% at 1 y 
 19 32 Double 53% at 2 y 31.2% at 2 y 34% at 2 y 
 40 50 Double 54% at 1 y 46% at 1 y 24% at 1 y 
 91 65 Double 55% at 3 y 34% at 3 y 15% at 3 y 
 21 21 Double 71% at 2 y 55% at 2 y 19% at 6 mo 
View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal